Kairos Pharma KAPA
NYSE KAPA
$0.54 -0.06 (-10.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Kairos Pharma (KAPA) Ending Cash Balance (2023 - 2025)

Updated

Analysis

Kairos Pharma (KAPA) Ending Cash Balance (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 6.57 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 3.18 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 1.03 Bn
10 Kairos Pharma 11.24 Mn -1.17 Mn - 4.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.49 Mn
Jun 30, 2025 3.03 Mn
Mar 31, 2025 3.62 Mn
Dec 31, 2024 1.27 Mn
Sep 30, 2024 3.22 Mn
Jun 30, 2024 21,000.00
Mar 31, 2024 40,000.00
Dec 31, 2023 93,000.00
Sep 30, 2023 99,000.00
API Access

Kairos Pharma Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=KAPA&period=max&api_key=YOUR_API_KEY